Recent Headlines
A CDC advisory panel is grappling with the best way to “do no harm” regarding Johnson & Johnson’s COVID-19 vaccine and its risk of blood clots.
-
Why might some COVID-19 vaccines pose a small risk of blood clots while others don’t? Scientists suspect it’s related to their use of adenoviruses.
-
NASA’s experimental Mars helicopter rises from the dusty red surface into the planet’s thin air, achieving the first powered flight on another planet.
-
Dr. Anthony Fauci says the U.S. will likely move to resume Johnson & Johnson’s COVID-19 vaccine this week after reports of six rare blood clot cases.
Experts said that while the pause on Johnson & Johnson’s vaccine may make sense for the U.S., stoppages in poorer countries would end up costing lives.
Researchers are developing vaccines that could be taken as a capsule, a dissolvable tablet or a nasal spray. But the barriers to success are high.
The goal is to have a pediatric vaccine available for all ages from 6 months to adulthood
U.S. health advisors told the government that they need more evidence to decide whether a handful of unusual blood clots were linked to the shot — and if so, how big the potential risk is.
Reports of blood clots among those who got Johnson & Johnson’s COVID-19 vaccine may make some recipients anxious. Here’s how to handle those feelings.
Two COVID-19 vaccines have now been linked to a risk of developing blood clots. Scientists don’t know whether the vaccines are to blame.
The Centers for Disease Control and Prevention extended its eviction moratorium through the end of June. There were scientific reasons for doing so.
U.S. health officials say women seeking an abortion pill will not be required to visit a doctor’s office or clinic during the COVID-19 pandemic.
Health news, ideas, advice and commentary.
Most Read
-
Lose it? Laminate it? Post it on Instagram? Some dos and don’ts for your vaccination card, the most exciting piece of paper you’ll get this year.
-
A lot of things are different when you’re in the midst of a global pandemic. A case in point: How federal regulators scrutinize and authorize new vaccines.
-
The second shot of the COVID vaccine does not need to happen precisely 21 or 28 days after the first to be effective.
We explain what vaccine passports are, how they work, where they’ve been implemented, and why some people object to them.
Up to 60 countries may be stalled at the first shots of their COVID-19 vaccinations because nearly all deliveries are blocked until as late as June.
New versions of COVID-19 vaccines are now being tested in case they ever are needed to protect against mutated versions of the virus.
With coronavirus cases and related hospitalizations climbing nationwide, is California also headed for a fourth wave in the COVID-19 pandemic?
More Coverage
A past coronavirus infection may eliminate the need for a second dose of COVID-19 vaccine, a growing body of evidence suggests.
The COVID-19 death toll in California represents 10.7% of all such deaths nationwide. California is home to about 12% of Americans.
One-third of COVID-19 survivors were diagnosed with a psychiatric or neurological condition within six months of being infected with the coronavirus.
Two COVID-19 vaccines are likely to be protective against a rapidly spreading variant of the SARS-Cov-2 virus that arose in California, a study finds.
After the EU cites a ‘possible link’ between the AstraZeneca vaccine and rare blood clots, British authorities say some adults should get a different shot.
Covid-19 Vaccines
The county’s latest allocation, approximately 362,000 doses, is up nearly 39,000 from last week, according to the Department of Public Health.
-
Public health officials worry that their budgets will be slashed when the pandemic recedes and they’ll once again be unprepared for a health crisis.
-
Still, California ranks 32nd among all states in the proportion of its population that’s considered fully vaccinated, according to the CDC.
-
California officials say they do not plan to require vaccine verification, but new rules incentivize private venues to seek proof of tests or inoculation.
-
Half of all adults in the U.S. have now received at least one COVID-19 shot
-
Vaccine hunters are the unofficial heroes of the coronavirus age. Wielding smartphones and tablets, PCs and Macs, these internet wranglers blast through barriers that stand between loved ones’ arms and COVID vaccines.
More headlines
-
Patrick Radden Keefe’s much-anticipated “Empire of Pain” lays it all bare
-
Results from two sets of experiments in Europe and the U.S. are creating cracks in the 50-year-old rulebook of the universe called the Standard Model.
-
The heavy concentration of new coronavirus cases in just five states is putting pressure on the government to consider adjusting vaccine distribution.
-
New U.S. research shows most kids with a serious inflammatory illness called MIS-C linked to the coronavirus were symptom-free or had mild infections.
-
A top official at Europe’s drugs regulator says there’s a link between AstraZeneca’s COVID-19 vaccine and a handful of cases of blood clots.
-
Vermont gave Black adults and people from other minority communities priority status for COVID-19 vaccinations. It joined Montana, which did so in January.
-
German officials have decided to limit the use of AstraZeneca’s coronavirus vaccine in people younger than 60 after more unusual blood clots were reported.
-
Pfizer says its vaccine works well for children as young as 12, raising hopes for the effectiveness of inoculations before the new school year.
-
The Easter Sunday holiday is going be a big test of whether California can avoid another COVID-19 spike, experts say.
-
The U.S. government’s first look at the real-world use of COVID-19 vaccines found their effectiveness was nearly as robust as in controlled studies.
-
With COVID-19 vaccines becoming more and more available, it’s hard for some people not to feel left out.
Get our free Coronavirus Today newsletter
Sign up for the latest news, best stories and what they mean for you, plus answers to your questions.
You may occasionally receive promotional content from the Los Angeles Times.